6,492
Views
142
CrossRef citations to date
0
Altmetric
Original Articles

Stage at diagnosis and colorectal cancer survival in six high-income countries: A population-based study of patients diagnosed during 2000–2007

, , , , , , , , , , , , , , , , , , , , , & show all
Pages 919-932 | Received 09 Aug 2012, Accepted 02 Jan 2013, Published online: 15 Apr 2013

References

  • Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001;2:533–43.
  • Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA: A cancer journal for clinicians 2011;61:69–90.
  • Coleman MP, Quaresma M, Berrino F, Lutz J-M, De Angelis R, Capocaccia R, et al. Cancer survival in five continents: A worldwide population-based study (CONCORD). Lancet Oncol 2008;9:730–56.
  • Berrino F, Capocaccia R, Coleman MP, Estève J, Gatta G, Hakulinen T, et al. EUROCARE-3: The survival of cancer patients diagnosed in Europe during 1990–94. Ann Oncol 2003;14(Suppl. 5):1–155.
  • Brenner H, Bouvier AM, Foschi R, Hackl M, Larsen IK, Lemmens V, et al. Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: The EUROCARE study. Int J Cancer 2012;131:1649–58.
  • Gatta G, Ciccolallo L, Capocaccia R, Coleman MP, Hakulinen T, Moller H, et al. Differences in colorectal cancer survival between European and US populations: The importance of sub-site and morphology. Eur J Cancer 2003;39:2214–22.
  • Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): An analysis of population-based cancer registry data. Lancet 2011;377: 127–38.
  • House of Commons Committee of Public Accounts. Delivering the Cancer Reform Strategy. [cited 2012 Mar 30]. Available from: http://www.publications.parliament.uk/pa/cm201011/cmselect/cmpubacc/667/667 pdf 2011 March 1; HC667, Session 2010–11.
  • Maringe C, Walters S, Butler J, Coleman MP, Hacker N, Hanna L, et al. Stage at diagnosis and ovarian cancer survival: Evidence from the International Cancer Benchmarking Partnership. Gynecol Oncol 2012;127:75–82.
  • Gatta G, Capocaccia R, Sant M, Bell CM, Coebergh JW, Damhuis RA, et al. Understanding variations in survival for colorectal cancer in Europe: A EUROCARE high resolution study. Gut 2000;47:533–8.
  • Ciccolallo L, Capocaccia R, Coleman MP, Berrino F, Coebergh JW, Damhuis RA, et al. Survival differences between European and US patients with colorectal cancer: Role of stage at diagnosis and surgery. Gut 2005;54:268–73.
  • Walters S, Maringe C, Butler J, Brierley JD, Rachet B, Coleman MP. Comparability of stage data in cancer registries in six countries: Lessons from the International Cancer Benchmarking Partnership. Int J Cancer 2013;132:676–85.
  • Laurenti R, Coleman MP, Aylin P. Accuracy of statements of the cause of death on death certificates and the international comparability of mortality statistics. In: Coleman MP, Aylin P, editors. Death certification and mortality statistics: An international perspective. London: Office for National Statistics; 2000.
  • Pohar-Perme M, Stare J, Estève J. On estimation in relative survival. Biometrics 2011;68:113–20.
  • Lambert PC, Royston P. Further development of flexible parametric models for survival analysis. The Stata Journal 2009;9:265–90.
  • Royston P, Lambert PC. Flexible parametric survival analysis using stata: Beyond the Cox Model. College Station, Texas: Stata Press; 2011.
  • Remontet L, Bossard N, Belot A, Estève J, FRANCIM. An overall strategy based on regression models to estimate relative survival and models to estimate relative survival and model the effects of prognostic factors in cancer survival studies. Stat Med 2007;26:2214–28.
  • Royston P. Multiple imputation of missing values: Update of ice. The Stata Journal 2005;5:527–36.
  • White IR, Royston P, Wood AM. Multiple imputation using chained equations: Issues and guidance for practice. Stat Med 2011;30:377–99.
  • Nur U, Shack LG, Rachet B, Carpenter JR, Coleman MP. Modelling relative survival in the presence of incomplete data: A tutorial. Int J Epidemiol 2010;39:118–28.
  • Rubin DB. Multiple imputation for nonresponse in surveys. New York: John Wiley and Sons; 1987.
  • Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985;312:1604–8.
  • Talbäck M. Cancer patient survival in Sweden – theory and application. PhD thesis Karolinska Institutet, Sweden; 2011.
  • Woods LM, Coleman MP, Lawrence G, Rashbass J, Berrino F, Rachet B. Evidence against the proposition that ‘UK cancer survival statistics are misleading’: Simulation study with national cancer registry data. BMJ 2011;342:d3399.
  • Folkesson J, Engholm G, Ehrnrooth E, Kejs AM, Påhlman L, Harling H, et al. Rectal cancer survival in the Nordic countries and Scotland. Int J Cancer 2009;125:2406–12.
  • Canadian Partnership Against Cancer. Colorectal cancer staging and survival. [cited 2012 Mar 30]. Available from: http://www cancerview ca/idc/groups/public/documents/webcontent/rl_crc_snapshot_three_en pdf 2010 November.
  • Angell-Andersen E, Tretli S, Coleman MP, Langmark F, Grotmol T. Colorectal cancer survival trends in Norway 1958–1997. Eur J Cancer 2004;40:734–42.
  • Morris EJ, Taylor EF, Thomas JD, Quirke P, Finan PJ, Coleman MP, et al. Thirty-day postoperative mortality after colorectal cancer surgery in England. Gut 2011;60:806–13.
  • Birgisson H, Talbäck M, Gunnarsson U, Påhlman L, Glimelius B. Improved survival in cancer of the colon and rectum in Sweden. Eur J Surg Oncol 2005;31:845–53.
  • Monnet E, Faivre J, Raymond L, Garau I. Influence of stage at diagnosis on survival differences for rectal cancer in three European populations. Br J Cancer 1999;81:463–8.
  • Engholm G, Kejs AM, Brewster DH, Gaard M, Holmberg L, Hartley R, et al. Colorectal cancer survival in the Nordic countries and the United Kingdom: Excess mortality risk analysis of 5 year relative period survival in the period 1999 to 2000. Int J Cancer 2007;121:1115–22.
  • Morris EJ, Sandin F, Lambert PC, Bray F, Klint A, Linklater K, et al. A population-based comparison of the survival of patients with colorectal cancer in England, Norway and Sweden between 1996 and 2004. Gut 2011;60:1087–93.
  • Klint A, Engholm G, Storm HH, Tryggvadóttir L, Gislum M, Hakulinen T, et al. Trends in survival of patients diagnosed with cancer of the digestive organs in the Nordic countries 1964 - 2003 followed up to the end of 2006. Acta Oncol 2010;49:578–607.
  • Zafar SY, Abernethy AP, Abbott DH, Grambow SC, Marcello JE, Herndon JE, et al. Comorbidity, age, race and stage at diagnosis in colorectal cancer: A retrospective, parallel analysis of two health systems. BMC Cancer 2008;8:345.
  • Mandelblatt J, Andrews H, Kao R, Wallace R, Kerner J. The late-stage diagnosis of colorectal cancer: Demographic and socioeconomic factors. Am J Publ Health 1996;86:1794–7.
  • Rudy DR, Zdon MJ. Update on colorectal cancer. Am Fam Physician 2000;61:1759–74.
  • National Cancer Institute. International Screening Network: Inventory of colorectal cancer screening activities in ICSN Countries. 2009.
  • Mitry E, Bouvier AM, Esteve J, Faivre J. Improvement in colorectal cancer survival: A population-based study. Eur J Cancer 2005;41:2297–303.
  • National Institute for Clinical Excellence. Guidance on cancer services: Improving outcomes in colorectal cancers. [cited 2012 Mar 30]. Available from: http://www.nice.org.uk/nicemedia/live/10895/28832/28832.pdf 2004
  • Canadian Partnership Against Cancer. Cancer Practice Guidelines Status Report: Colorectal Cancer. [cited 2012 Mar 30]. Available from: http://www.cancerview.ca/idc/groups/public/documents/webcontent/cep_colorec_guid_stsrpt.pdf 2010 July
  • Korsgaard M, Pedersen L, Laurberg S. Delay of diagnosis and treatment of colorectal cancer – a population-based Danish study. Cancer Det Prev 2008;32:45–51.
  • Christensen LH, Engholm G, Ceberg J, Hein S, Perfekt R, Tange UB, et al. Can the survival difference between breast cancer patients in Denmark and Sweden 1989 and 1994 be explained by patho-anatomical variables? – A population-based study. Eur J Cancer 2004;40:1233–43.
  • Olesen F, Hansen RP, Vedsted P. Delay in diagnosis: The experience in Denmark. Br J Cancer 2009;101(Suppl 2):5–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.